Furthermore, the downregulation of CHST6, SFXN2, and GRIK3 upon miR-134-5p overexpression indicates that miR-134-5p may modulate mitochondrial dynamics and metabolic pathways essential for ccRCC progression. The gene discussed is CHST6; the disease is nonpapillary renal cell carcinoma.